Last reviewed: August 30, 2026. Educational content for adults 21+. This is not medical or legal advice. Kiody does not sell concentrated 7-OH products.
Suggested page / content hub: Learning Center → Lab Testing & Product Quality
Suggested URL slug: /learn/kratom-cleaning-validation-changeover-controls/
Review date: August 30, 2026
Why cleaning is a product-quality question
Cleaning is sometimes treated as a housekeeping subject. In manufacturing, it is also a product-control subject.
Residue from a previous run can affect the next run’s:
- identity;
- composition;
- strength or constituent profile;
- color and sensory characteristics;
- microbiological status;
- allergen or ingredient declaration;
- legal classification; and
- lot traceability.
Consider a facility that fills pure-leaf capsules after running a concentrated extract through the same contact equipment. If the equipment is not adequately cleaned, the following batch may no longer be only pure leaf. The problem is not resolved by calling the amount “small.” The manufacturer needs evidence about what transferred, whether it exceeded a justified limit, whether the label remains accurate and whether the affected material can be released at all.
The concern becomes more serious when the previous product contains a prohibited or differently regulated substance. An operation that handles concentrated 7-OH, mitragynine pseudoindoxyl, MGM-15 or MGM-16 cannot treat carryover into botanical leaf as ordinary color variation. Federal legal status, state thresholds and the finished product’s claims may all be affected.
The federal quality framework—and its limits
FDA’s dietary-supplement current good manufacturing practice regulation requires written procedures for maintaining, cleaning and sanitizing, as necessary, equipment, utensils and other contact surfaces. Equipment must be designed and installed so it can be adequately cleaned and properly maintained. Low-moisture contact surfaces must be dry and sanitary when used; after wet cleaning, they must be thoroughly dried before subsequent use. The regulation also requires cleaning records, including individual equipment logs unless the information is kept with the batch record.
Quality-control personnel must review and approve processes, specifications, procedures, controls and deviations that can affect product identity, purity, strength or composition. An unanticipated occurrence that may lead to adulteration requires material review and a documented disposition decision.
Those requirements are useful quality benchmarks. They should not be turned into a claim that FDA has approved a specific kratom product or decided that kratom may lawfully be sold as a dietary supplement. FDA’s current public position on kratom remains separate from the manufacturing-control concepts discussed here.
FDA’s older inspection guide on cleaning validation was written for drug manufacturing, not specifically for retail botanical products. It is therefore not presented here as a kratom-specific legal requirement. Its enduring documentation questions are nevertheless useful: What residue is being controlled? Where is the hardest location to clean? How was the sampling method chosen? Can the analytical method detect the residue at the acceptance level? What happens after a failure?
Cleaning, sanitizing, verification and validation
Cleaning
Cleaning is the physical and chemical removal of residue and soil. A procedure may use controlled vacuuming, brushing, wiping, disassembly, washing, rinsing or another justified method. The right approach depends on equipment design, the product, the residue and whether adding water creates a larger hazard.
Dry botanical powder presents a special challenge. It can become airborne, migrate into bearings or controls, and settle far from the visible process. Wetting it may form a paste that is harder to remove. Introducing water can also create a microbial concern if equipment is not fully dried.
Sanitizing
Sanitizing is not a substitute for cleaning. Organic material and powder can shield microorganisms or interfere with a sanitizing agent. The surface should first be cleaned to the defined condition. The operation then decides where sanitation is necessary and uses an agent, concentration, contact time and application method appropriate for the intended use.
Sanitizing also is not the same as sterilizing. A facility should not use “sterile” language unless it has an entirely different level of supported control.
Verification
Verification answers: Did this cleaning event meet the established requirements?
Examples include:
- inspection after equipment is opened;
- a checklist confirming that specified parts were removed;
- a targeted swab result;
- a rinse result;
- confirmation that surfaces are dry;
- review of detergent concentration or contact time;
- inspection of a filter, screen or vacuum canister; and
- documented line clearance before the next lot begins.
Verification may occur after every changeover, at a risk-based frequency or after specified triggers. The plan should state which approach applies.
Validation
Validation answers: Does this defined procedure repeatedly work for its intended purpose?
A useful validation study identifies:
- the equipment and product family;
- the exact procedure;
- the residue or contamination risk being measured;
- the hardest-to-clean locations;
- the worst-case product or process;
- the acceptance criteria;
- the sampling method;
- the analytical method and its capability;
- the number and type of successful runs;
- deviations and investigations; and
- the conditions that require revalidation.
Validation is not a one-time ceremonial swab. It is an evidence package tied to a specific procedure and operating range.
Dry cleaning versus wet cleaning
There is no universal answer that says every kratom-contact surface should always be dry-cleaned or always be wet-cleaned.
Dry-cleaning considerations
Dry cleaning may be appropriate for low-moisture powders when water would spread residue, cause caking, damage equipment or create a drying challenge. A controlled procedure may use a dedicated food-contact vacuum, disassembly, scraping with suitable tools and single-use or controlled reusable wipes.
Risks include:
- moving powder from one area to another instead of capturing it;
- aerosolizing fine material with compressed air;
- leaving residue in a dead leg or gasket;
- reusing a contaminated brush or vacuum attachment; and
- mistaking absence of visible color for absence of residue.
FDA’s equipment rule specifically says compressed air or gases introduced onto a component, dietary supplement or contact surface must be treated so they do not contaminate it. Blowing powder across a room is not a controlled changeover.
Wet-cleaning considerations
Wet cleaning can dissolve or suspend residues and may support subsequent sanitation. It also introduces variables:
- water quality;
- detergent identity and concentration;
- temperature;
- mechanical action;
- contact time;
- rinse completeness;
- drainage; and
- drying time.
FDA’s rule requires contact surfaces used for low-moisture components or supplements to be dry and sanitary when in use. When they are wet-cleaned, they must be thoroughly dried before later use. A signed form stating “washed” does not answer whether a hollow tube, valve seat or gasket groove remained wet.
Hybrid procedures
Some equipment may require a staged approach: controlled dry removal of bulk powder, disassembly, targeted wet cleaning of washable parts, sanitation where necessary, drying and protected storage. A hybrid procedure is acceptable only when each stage is defined and the whole sequence is shown to work.
Start with an equipment and product map
A cleaning program should begin before anyone chooses a swab.
Map the product path from receiving through final packaging. For a leaf-powder or capsule operation, the map may include:
- receiving scoops and sampling thieves;
- quarantine and dispensing containers;
- scales and balance pans;
- sifters and screens;
- mills;
- transfer hoses;
- bins and intermediate-bulk containers;
- ribbon blenders or V-blenders;
- discharge valves;
- dust collectors;
- capsule hoppers, dosing assemblies and polishing equipment;
- conveyors;
- metal detectors;
- filling funnels;
- packaging contact parts; and
- rework or returned-material containers.
For liquids or extracts, add tanks, agitators, pumps, valves, hoses, nozzles, recirculation loops and fill heads.
Then identify product categories. A sensible matrix does not assume that green, red and white commercial variety names are chemically identical. It also does not automatically treat leaf, native extract, standardized extract, flavored liquid and concentrated 7-OH as one cleaning family.
Where residue hides
The easiest flat surface is rarely the best validation site. Hard-to-clean locations often include:
- the underside of an agitator blade;
- a gasket groove;
- threads;
- a valve seat;
- a flexible hose connection;
- a weld that is rough or damaged;
- a blender discharge transition;
- a capsule-machine dosing disk;
- the joint between removable and fixed parts;
- a recessed fastener;
- a dust-collection branch;
- the underside of a screen frame; and
- any area with poor drainage.
Equipment design matters. FDA requires seams to be smoothly bonded or maintained to minimize accumulation of particles, organic material and contaminants. If routine cleaning cannot reach a location, the long-term answer may be equipment modification or replacement—not ever more creative paperwork.
Product-to-product risk ranking
A changeover assessment can rank both the outgoing and incoming products.
Questions about the outgoing product include:
- Is it plain botanical leaf, an extract or a multi-ingredient formula?
- Is the material sticky, oily, electrostatic or strongly colored?
- Does it contain a concentrated marker that is easy to detect?
- Does it contain an allergen or undeclared flavor ingredient?
- Is any constituent prohibited in the next product or destination?
- Does it contain a scheduled substance?
- How much material typically remains after discharge?
Questions about the incoming product include:
- Is its label limited to pure leaf?
- Is it intended for a jurisdiction with a strict product threshold?
- Is the next lot lighter in color, lower in a measured constituent or otherwise more sensitive to carryover?
- Is the next batch small, making a fixed amount of residue proportionally larger?
- Will the product be tested with a method capable of detecting the likely carryover?
A sequence from one plain-leaf lot to another is not automatically risk-free. A sequence from a highly concentrated or legally prohibited compound into pure leaf is plainly not equivalent to a routine color change.
Dedicated equipment and campaign manufacturing
Cleaning is only one control option.
Some risks may justify:
- dedicated scoops or utensils;
- dedicated rooms or enclosed systems;
- disposable contact parts;
- segregated dust collection;
- production campaigns that group similar products;
- running lower-risk products before higher-risk ones;
- additional line clearance; or
- refusing to manufacture incompatible categories in the same facility.
Dedicated equipment does not eliminate the need for maintenance and cleaning. It reduces certain cross-product risks. Shared air, personnel, wheels, tools and dust can still move material outside the nominal product-contact path.
For a brand that promises pure botanical leaf and does not sell concentrated 7-OH, supplier qualification should ask whether its contract facility handles concentrated 7-OH, scheduled derivatives or other high-risk compounds anywhere on the premises. A “no” answer should be documented. A “yes” answer should trigger a far deeper assessment than a generic certificate saying the site follows GMP.
Defining the residue of concern
“Clean” cannot be measured until the residue of concern is defined.
Possible targets include:
- visible botanical powder;
- total organic residue;
- a specific alkaloid marker;
- a flavor or color marker;
- detergent residue;
- microbiological contamination;
- an allergenic ingredient; and
- moisture remaining after wet cleaning.
One test rarely covers every target.
An ATP test can provide rapid information about biological residue but is nonspecific and does not prove absence of a particular alkaloid. A microbiological swab can evaluate recoverable organisms under the test conditions but does not establish chemical cleanliness. A targeted LC-MS or LC-MS/MS method may detect a specific alkaloid yet say nothing about detergent or moisture. Visual inspection remains useful, but it should not be asked to detect invisible residue.
Acceptance criteria must be decided before testing
A result should not be interpreted by inventing a limit after the laboratory reports a number.
The cleaning protocol should state in advance:
- what is being measured;
- the unit of measurement;
- the limit;
- whether the limit applies per swab, per square area, per equipment train or by estimated carryover into the next batch;
- how nondetects are treated;
- the required method reporting limit;
- the rule for results near the limit; and
- the disposition after a failure.
“Not detected” is meaningful only in relation to a method and reporting limit. If the acceptance criterion is 5 micrograms per swab but the laboratory cannot reliably report below 20 micrograms per swab, an ND result cannot demonstrate compliance with the 5-microgram criterion.
The limit also needs a defensible basis. A company should not import a pharmaceutical rule of thumb, apply a percentage of a purported dose or copy another facility’s limit without showing why it protects the identity, composition, labeling and legal status of its own product.
For a scheduled or prohibited substance, an internally selected housekeeping limit cannot create legal permission. Regulatory and legal requirements come first.
Sampling a cleaned surface
Swab sampling
A swab samples a defined accessible area. A useful record identifies:
- swab material;
- wetting solvent, if any;
- area sampled;
- surface material;
- exact location;
- direction and pattern;
- operator;
- time after cleaning;
- time before analysis;
- storage and transport conditions; and
- laboratory method.
Recovery studies matter. A swab may recover a different percentage from polished stainless steel than from silicone, plastic, scratched metal or rubber. If 10 micrograms are placed on a test surface and the complete sampling-and-analysis process reports an average of 6 micrograms, the recovery is 60% under those study conditions. The procedure should explain whether and how recovery is considered.
Rinse sampling
A rinse may reach an enclosed path that cannot be swabbed. It also dilutes residue and can average a large system, potentially hiding one localized pocket. The record should specify rinse volume, solvent, contact method, recirculation time, collection point and calculation basis.
Product or placebo flushes
A facility may pass a defined material through equipment and test the recovered material. This can model carryover into a subsequent run, but it can also spread residue and create additional material requiring disposition. A flush is not automatically rework and should not be returned to saleable product without an approved basis.
Visual inspection
Visual inspection is fast and should be structured: adequate lighting, opened equipment, specified viewing locations and trained personnel. It is strongest when paired with other methods chosen for the residue risk. “Looks clean from the doorway” is not line clearance.
Analytical-method questions
A sophisticated instrument name does not make a cleaning result reliable. Ask:
- Is the method specific to the target?
- Does the swab or rinse solvent extract the target from the surface?
- Are blank swabs and field blanks included?
- Could the cleaning agent interfere?
- Are the limit of detection and limit of quantitation low enough?
- Is the calibration range appropriate?
- Was recovery evaluated on representative surfaces?
- Does the laboratory report the result per swab, per area or per volume?
- Is measurement uncertainty relevant near the acceptance boundary?
- Can the method distinguish 7-OH from closely related compounds?
For botanical residue, mitragynine may be a useful marker in some situations, but a single marker does not represent every possible constituent. For changeovers involving concentrated 7-OH or a scheduled derivative, a method that measures only mitragynine is not fit for that specific purpose.
Worst-case selection
A cleaning validation study often brackets similar products rather than testing every possible sequence. The bracket is credible only when the “worst case” is justified.
Factors may include:
- highest constituent concentration;
- lowest solubility in the cleaning system;
- greatest adhesion;
- darkest pigment;
- smallest following batch;
- most difficult equipment geometry;
- longest dirty hold time;
- hardest surface material;
- manual-cleaning variability; and
- most consequential legal or labeling carryover.
The product with the highest assay is not always hardest to clean. A lower-assay sticky extract may leave more residue than a higher-assay free-flowing powder. Worst-case selection should consider both residue amount and removability.
Dirty hold time and clean hold time
Dirty hold time is the period between the end of processing and the start of cleaning. Residue may dry, harden, oxidize or migrate during that period.
Clean hold time is the period between completed cleaning and reuse. During storage, equipment may collect dust, moisture or microbial contamination, especially if it is left open or improperly protected.
A validated procedure should state its applicable windows. If validation used a two-hour dirty hold but routine production leaves equipment overnight, the evidence does not automatically cover the longer condition. If cleaned parts were validated for protected storage for three days, a part left uncovered for ten days requires evaluation before use.
Line clearance is more than equipment washing
A successful changeover also removes or controls:
- previous-product labels;
- printed packaging;
- scoops and utensils;
- component containers;
- in-process samples;
- rejects;
- rework;
- dust on nearby structures;
- electronic recipe selections; and
- documents displayed at the line.
This is where cleaning and batch-record controls meet. A spotless hopper cannot prevent the wrong label from being applied. Quality review should confirm both physical clearance and documentation clearance.
What a complete cleaning record should contain
Kiody could request or internally maintain a cleaning/changeover record with at least these 30 fields:
- facility and room;
- equipment name;
- unique equipment ID;
- previous product;
- previous lot;
- next product;
- next lot or planned batch;
- product-form risk category;
- end-of-run time;
- cleaning-start time;
- dirty hold time;
- approved procedure and version;
- parts disassembled;
- dry-cleaning steps;
- wet-cleaning steps;
- cleaning-agent identity;
- concentration or preparation record;
- contact time;
- rinse details;
- drying method and completion;
- hard-to-clean locations inspected;
- verification sampling locations;
- sample IDs;
- test methods;
- acceptance criteria;
- results;
- visual-inspection result;
- operator signature and time;
- independent or quality review; and
- release, reclean or investigation disposition.
The record should make it possible to reconstruct what happened. A preprinted checkmark beside “cleaned per SOP” cannot replace all of the underlying information when the procedure or event is under investigation.
What happens when cleaning verification fails
A failed swab should not be erased by repeated cleaning and retesting without an investigation.
A controlled response may include:
- keep the equipment out of service;
- identify every affected location;
- determine whether the next product was already manufactured;
- quarantine potentially affected materials;
- review execution of the cleaning procedure;
- examine equipment condition and disassembly;
- check sampling and laboratory performance;
- reclean under an approved instruction;
- resample according to a predefined or scientifically justified plan;
- assess previous batches if the failure indicates a recurring problem;
- document the material-review and disposition decision; and
- implement corrective and preventive action when appropriate.
A passing result after recleaning may demonstrate that the second cleaning event met its criteria. It does not prove the first event was acceptable or eliminate the need to assess product made after that first event.
Five worked scenarios
Scenario 1: Green leaf to red leaf in the same blender
The outgoing and incoming products are both ground botanical leaf, but they have different lot identities and commercial variety names. The blender is discharged, opened, dry-cleaned and visually inspected at defined locations. A risk-based verification procedure checks the discharge gasket and underside of the ribbon.
Review: This is a lower-risk changeover than extract-to-leaf, but it still needs traceability and line clearance. Color alone is not proof of cleanliness, and variety names do not establish chemical equivalence.
Scenario 2: Extract to pure-leaf capsules
A contract facility makes standardized extract capsules and then approximately 500 mg pure-leaf capsules on shared encapsulation equipment. It shows a general sanitation certificate but no product sequence, targeted residue method or dosing-disk sampling.
Review: The evidence is incomplete. A pure-leaf claim depends on controlling extract carryover. Ask whether extract and leaf have dedicated contact parts, what marker was selected, whether recovery was evaluated on the dosing assembly and how the next batch was assessed.
Scenario 3: Wet-cleaned powder blender remains damp
Operators wash a blender at the end of the shift and close it before all recesses are dry. The next morning, visible droplets remain near the discharge seal.
Review: Do not release the equipment based only on yesterday’s signed cleaning line. FDA’s dietary-supplement equipment rule specifically requires low-moisture contact surfaces to be dry and sanitary when used. Document the deviation, assess the equipment and any exposed material, and correct the drying or storage process.
Scenario 4: Pass after a second swab
The first mitragynine swab exceeds the cleaning limit. The location is wiped again, and a second swab passes. The first result is crossed out as “operator error.”
Review: That is not a defensible disposition without evidence. The first result may show an inadequate cleaning event or a sampling problem. Preserve both results, investigate the cause, determine whether other locations or batches are affected and document the decision.
Scenario 5: Facility handles scheduled derivatives
A supplier says it manufactures botanical leaf in one room and mitragynine pseudoindoxyl, MGM-15 or MGM-16 elsewhere in the building. It offers a generic cleaning SOP as assurance.
Review: Those substances entered federal Schedule I on August 26, 2026. A generic SOP is not enough to establish lawful handling or prevent facility-wide transfer. Confirm authorization, segregation, air and personnel flows, waste controls, dedicated systems, analytical capability and legal review. Kiody should not accept product merely because a conventional cleaning checklist was signed.
Current federal 7-OH note
As reviewed August 30, 2026, the federal threshold for 7-OH remained proposed, with the HHS comment period extended through September 10, 2026. That proposal should not be described as an effective final threshold.
A separate DEA temporary order became effective August 26, 2026 and placed mitragynine pseudoindoxyl, MGM-15 and MGM-16 in Schedule I. The two federal actions are distinct. A cleaning program should not combine them into one generic “7-OH rule,” and a quality acceptance limit cannot override controlled-substance law.
Questions a retailer can ask without requesting trade secrets
A responsible supplier does not need to reveal a proprietary formula to answer basic control questions.
Ask:
- Does the facility manufacture leaf, extracts and concentrated alkaloid products on shared equipment?
- Does it handle concentrated 7-OH, MP, MGM-15 or MGM-16 anywhere onsite?
- Are written cleaning and line-clearance procedures maintained?
- What triggers enhanced verification?
- Are hard-to-clean locations identified by equipment ID?
- Are cleaning events recorded in equipment logs or batch records?
- Are failures investigated rather than simply retested?
- Are dry-contact surfaces confirmed dry after wet cleaning?
- Are brushes, vacuums, hoses and utensils dedicated or controlled?
- Are analytical methods capable at the acceptance criteria?
- Does quality review and release the equipment?
- What changes trigger revalidation?
The answer “we clean between batches” is a starting point, not a complete control system.
Warning signs in cleaning documentation
Watch for:
- one identical checklist for every equipment type;
- no unique equipment IDs;
- no previous and next product information;
- “visually clean” without opened-equipment locations;
- routine use of compressed air that spreads powder;
- no drying confirmation after wet cleaning;
- swab methods with reporting limits above the acceptance criteria;
- samples taken only from easy flat surfaces;
- no recovery study for swabs or rinse samples;
- undocumented brushes, hoses or vacuum attachments;
- repeated reclean-and-retest cycles with no investigation;
- a cleaning validation that never included worst-case residue;
- a study performed before a major equipment or formulation change;
- no treatment of dust collectors or room surfaces;
- no separation of cleaning-agent residue from product residue;
- no quality approval;
- missing dirty and clean hold times; and
- shared manufacture of scheduled compounds supported only by a general GMP statement.
Frequently asked questions
1. Does a clean appearance prove equipment is clean?
No. Visual inspection is useful for visible residue, equipment condition and obvious moisture. It cannot by itself establish absence of an invisible chemical, microbial or allergenic residue.
2. Is cleaning the same as sanitizing?
No. Cleaning removes residue and soil. Sanitizing reduces microorganisms on a cleaned surface when necessary. A sanitizer should not be expected to work through a layer of powder.
3. Is cleaning verification the same as cleaning validation?
No. Verification evaluates a particular event. Validation builds evidence that a defined procedure can repeatedly meet its intended criteria.
4. Must all dry-powder equipment be washed with water?
Not universally. The method should be selected for the equipment and risk. If low-moisture contact surfaces are wet-cleaned, FDA’s dietary-supplement rule requires them to be thoroughly dried before later use.
5. Can compressed air clean a powder room?
Uncontrolled compressed air can redistribute powder. FDA requires compressed air or gas introduced onto products or contact surfaces to be treated so it does not cause contamination. A facility should document when and how it is used.
6. What is a cleaning swab?
It is a sampling device used to collect residue from a defined surface area for analysis. Its usefulness depends on site selection, recovery, storage, method sensitivity and the acceptance criterion.
7. What does “ND” mean on a cleaning result?
It means the target was not detected under the method’s conditions. It does not mean absolute zero. Review the detection or reporting limit and confirm it is low enough for the cleaning criterion.
8. Does an ATP swab prove there is no kratom residue?
No. ATP is a rapid, nonspecific hygiene indicator. It does not specifically identify mitragynine, 7-OH or another kratom constituent.
9. Can mitragynine be used as the only cleaning marker?
It may be useful in a justified study, but it does not represent every ingredient or alkaloid. It is not adequate by itself for a changeover whose critical residue is 7-OH, MP, MGM-15, MGM-16, detergent or an allergen.
10. Why sample a gasket or valve instead of only the main wall?
Validation should challenge hard-to-clean locations. Residue often accumulates in joints, seals, threads, recesses and discharge paths rather than on an easily wiped flat wall.
11. What is line clearance?
It is confirmation that the prior product, components, labels, documents, rejects and residues have been removed or controlled before the next operation begins.
12. Does a passing finished-product COA prove the changeover was adequate?
Not necessarily. A COA covers the analytes, sample and methods shown. It may not test the previous product’s marker, and a composite sample may not reveal localized carryover.
13. Does a failed swab automatically mean the next lot is contaminated?
It establishes that the sampled cleaning condition did not meet its criterion or that the result requires investigation. The lot impact depends on timing, equipment use, residue, sampling evidence and a documented quality decision.
14. When should a procedure be revalidated?
Triggers can include new equipment, changed product formulation, new cleaning agent, revised disassembly, longer hold time, changed analytical method, repeated failures, major maintenance or addition of a harder-to-clean product.
15. Are pure-leaf capsules made from extract?
Not when accurately described as pure-leaf capsules. Kiody’s capsule description is approximately 500 mg of leaf powder per capsule, not extract. Shared-equipment controls should protect that distinction.
16. Does Kiody sell concentrated 7-OH?
No. Kiody is 21+ and does not sell concentrated 7-OH. This guide discusses high-risk changeovers so buyers can understand why supplier and facility controls matter.
A proposed Kiody quality standard
Before approving a contract manufacturer or high-risk supplier, Kiody could require documented answers to five questions:
- Scope: What product and compound categories are handled in the facility?
- Separation: Which rooms, air systems, tools and contact parts are shared or dedicated?
- Procedure: What approved cleaning and line-clearance instructions apply to the relevant equipment?
- Evidence: What validation, routine verification, method-suitability and failure records show the controls work?
- Release: Who independently reviews the record and authorizes the next product?
A quality promise becomes more trustworthy when it can be traced to equipment, procedure, result, reviewer and lot.
Primary and authoritative sources
- 21 CFR Part 111, Subpart D — Equipment and Utensils — written cleaning procedures, equipment design, dry-contact surfaces, cleaning, sanitation and records.
- 21 CFR Part 111, Subpart F — Quality Control — quality review, deviations, material review and disposition.
- FDA Small Entity Compliance Guide for Dietary Supplement CGMP — FDA’s explanatory guide to Part 111.
- FDA Dietary Supplement Inspection, Sampling and Import Compliance Program 7321.008 — current inspection framework issued August 18, 2025.
- FDA Inspection Guide to Cleaning Validation — older drug-manufacturing inspection guide used here only as a conceptual validation reference, not as a kratom-specific mandate.
- FDA BAM Chapter 1 — Food Sampling and Sample-Homogenate Preparation — sampling and preparation context.
- FDA BAM Chapter 3 — Aerobic Plate Count — official microbiological method context.
- FDA’s current kratom information — current federal agency position; cited to avoid implying product approval.
- HHS extension of the federal 7-OH threshold comment period — comments due September 10, 2026.
- DEA temporary Schedule I order for MP, MGM-15 and MGM-16 — effective August 26, 2026.